The pharmaceutical landscape for diabetes is changing, and transdermal GLP-1 delivery systems represent a potential development. Unlike subcutaneous injections, this technique offers a less invasive way to deliver https://kathrynqcdi024800.ourcodeblog.com/41374919/glp-1-patches-a-novel-approach-to-blood-sugar-treatment